RE:Insanity or indecency?THERA we are not faceless shareholders, we are people with Families, Children & Grandchildren, you have done a LOT of damage to us and most definitely to me.
I symbolically voted against the entire board in hopes of at least some minor (common sense) changes and to help send a strong message, however all we got was one minor change and what feels like retribution for challenging the board that is suppose to works for us.
It appears that they coerced some large holders into saving thier buts and then backed the bus right over them and the rest of us.....Maybe it would make a good bedtime story for their grandkids, teach them good life lesons while showing how solid thier morals are. NOT!
Sorry had to vent.
scarlet1967 wrote:
People who suffer from insanity don't have a choice. On the other hand people who are indecent have had a choice. To me the timing/terms of the first offering was ugly but the marathon loan was uglier. The last offering is by far the ugliest. They didn't only crush the valuation and loyal longterm shareholders but also their own already questionable credibility. Insider buying at multi year lows not far from all time lows doesn't make me feel any better about how badly they have managed the company. For those who weren't around at the time of the all time low valuation they had manufacturing issues with Egrifta which was the company's main and only asset. Now they have two commercial drugs and the R&D assets. Point is why the market ascribes almost the same value to the company now as it did in 2013? Who is responsible for the putting it mildly the negative perception? Name and shame who ever you think are responsible but surely they don't deserve their compensations on the contrary they should move on and let new folks do what they are not "capable" of doing.
This last offering to me was the last nail in the coffin. Unfortunately it's too late to sell so I guess the long term shareholders now have to put up but in my opinion never shut up. I voted against majority of the board members in the last few years next time round it will be against all of them. The scientific team in my opinion is a crucial part of the company now crushed too so the CEO can stay on his compensation. I had high expectations when he was appointed a marketing strategist with skills necessary to increase sales and present the company's business. The higher expectations if not materialized the higher disappointments and that's what I feel about it now. For those who claim the last round of layoffs don't include R&D folks involved with oncology feel free and check company's LinkedIn people page(while they are still there) and try to find 25 people who can be classified as R&D excluding the scientists involved in the oncology research. Good luck with that cause you need it. Yes very negative assessment but not far from the truth in my opinion.